Osteodoron PM Bone Support

Manufacturer: Uriel Pharmacy Inc
Effective date: 2010-03-12
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:02:13

Label at a glance#

ProductOsteodoron PM Bone Support

Active ingredientOYSTER SHELL CALCIUM CARBONATE, CRUDE, WHITE OAK BARK, CALCIUM FLUORIDE, SILICON DIOXIDE

Label structure10 sections

Contacts and useful links#

PhoneLabel contact866.642.2858

Websitewww.urielpharmacy.com

www.urielpharmacy.com

Label contents#

Full prescribing information#

Purpose

OTC - PURPOSE SECTION

Uses: For healthy teeth and bone development.

Dosage & Administration

DOSAGE & ADMINISTRATION SECTION

Directions: Take in the evening. Use with Osteodoron AM Bone Support Powder. Ages 12 and older: 1/8 tsp. Ages 2-11: 1/16 tsp. Under age 2: Ask a doctor.

OTC-Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Conchae 1X HPUS, Quercus e cort. 4X HPUS, Fluorite 6X HPUS, Quartz 6X HPUS.

Inactive Ingredient

INACTIVE INGREDIENT SECTION

Inactive Ingredient: Lactose

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

Do not use section

OTC - DO NOT USE SECTION

Warnings: Do not use if allergic to any ingredient. Do not use if safety seal is broken or missing.

Ask doctor section

OTC - ASK DOCTOR SECTION

Consult your doctor if you are lactose intolerant, or if inadequate dietary calcium is a concern. When using this product, consult your doctor regularly to ensure that improvement is proceeding normally.

Pregnancy or breast feeding section

OTC - PREGNANCY OR BREAST FEEDING SECTION

If you are pregnant or nursing, consult a doctor before use.

Questions section

OTC - QUESTIONS SECTION

Questions? Uriel Pharmacy
866.642.2858 East Troy, WI 53120

www.urielpharmacy.com

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Osteodoron PM

Bone Support Powder

Homeopathic

net vol. 60 ml (2 fl. oz.)

osteodoron PM powder bottle label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
48951-7097-4	2020-01-31	C162847	48780-1	9d75b9d0-1c96-f424-e053-dadaa90a57ce	Osteodoron PM Bone Support Powder - 60 ml

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
48951-7097-4	Osteodoron PM Bone Support	1 in 1 BOTTLE, GLASS	POWDER	1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
48951-7097	OSTEODORON PM BONE SUPPORT (OYSTER SHELL CALCIUM CARBONATE, CRUDE WHITE OAK BARK CALCIUM FLUORIDE SILICON DIOXIDE) POWDER [URIEL PHARMACY INC]	1	Legacy NDC, 1 package rows	20100312_1a8df250-2df2-11df-8a39-0800200c9a66.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CALCIUM FLUORIDE	ACTIVE INGREDIENT	O3B55K4YKI	1
OYSTER SHELL CALCIUM CARBONATE, CRUDE	ACTIVE INGREDIENT	2E32821G6I	1
SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	1
WHITE OAK BARK	ACTIVE INGREDIENT	93LP7Y8EGT	1
CALCIUM FLUORIDE	ACTIVE MOIETY	O3B55K4YKI	1
OYSTER SHELL CALCIUM CARBONATE, CRUDE	ACTIVE MOIETY	2E32821G6I	1
SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	1
WHITE OAK BARK	ACTIVE MOIETY	93LP7Y8EGT	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

Osteodoron PM Bone Support
OYSTER SHELL CALCIUM CARBONATE, CRUDE WHITE OAK BARK CALCIUM FLUORIDE SILICON DIOXIDE
OYSTER SHELL CALCIUM CARBONATE, CRUDE
WHITE OAK BARK
CALCIUM FLUORIDE
LACTOSE
SILICON DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
48951-7097	48951-7097-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
OYSTER SHELL CALCIUM CARBONATE, CRUDE	2E32821G6I	ACTIB
WHITE OAK BARK	93LP7Y8EGT	ACTIB
CALCIUM FLUORIDE	O3B55K4YKI	ACTIB
LACTOSE	J2B2A4N98G	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 36 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ff723fd0-2df1-11df-8a39-0800200c9a66			1a8df250-2df2-11df-8a39-0800200c9a66	2010-03-12		Exact identifier spl id: ff723fd0-2df1-11df-8a39-0800200c9a66 spl set id: 1a8df250-2df2-11df-8a39-0800200c9a66

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.